期刊文献+

自噬参与氧化性低密度脂蛋白诱导的血管平滑肌细胞钙化 被引量:11

Autophagy is Involved in Progression of Vascular Smooth Muscle Cell Calcification Induced by Ox-LDL
下载PDF
导出
摘要 【目的】观察细胞自噬是否参与了氧化型低密度脂蛋白(Ox-LDL)诱导的血管平滑肌细胞钙化。【方法】采用体外血管平滑肌细胞钙化模型,实验分为3组:control组:用nativeLDL处理细胞;Ox-LDL组:用Ox-LDL处理细胞;3MA组:用Ox-LDL和3MA处理细胞;细胞培养液为DMEM+10mMBGP。分别以茜素红检测血管钙化,Q-PCR和Westernblotting测定cbfa1和Beclin1的mRNA和蛋白表达。【结果】Ox-LDL加速血管平滑肌细胞钙化,上调cbfa1和Beclin1的表达;细胞自噬特异性抑制剂3MA减弱细胞钙化,下调cbfa1和Beclin1的表达。【结论】Ox-LDL诱导的血管平滑肌细胞钙化与细胞自噬有关。 【Objective】 To determine whether autophagy is involved in the process of vascular smooth muscle cell calcification induced by Ox-LDL. 【Methods】 The in vitro model of vascular calcification was used in this study. Vascular smooth muscle cells were randomly divided into controls,an Ox-LDL-treated group,and a 3MA plus Ox-LDL-treated group. Cells were grown in DMEM supplemented with 10 mM BGP. Calcification was assessed by alizarin red staining. The mRNA and protein expression of cbfa1 and Beclin1 were analyzed by Q-PCR and Western blotting respectively. 【Results】 Ox-LDL promotes vascular smooth muscle cell calcification,up-regulates the mRNA and protein expression of cbfa1 and Beclin1. The specific autophagy inhibitor attenuates vascular calcification,and inhibits the up-regulation of cbfa1 and Beclin1 expression induced by Ox-LDL. 【Conclusion】 The pathogenesis of vascular smooth muscle cell calcification induced by Ox-LDL involves autophagy.
出处 《中山大学学报(医学科学版)》 CAS CSCD 北大核心 2010年第6期772-775,共4页 Journal of Sun Yat-Sen University:Medical Sciences
基金 国家自然科学基金(81000124) 广东省医学科研基金(A2010037)
关键词 氧化型低密度脂蛋白 自噬 血管平滑肌细胞 钙化 oxidized low density lipoprotein autophagy vascular smooth muscle cells calcification
  • 相关文献

参考文献11

  • 1陆立鹤,刘兰,谭红梅,张选红.Biglycan对地塞米松诱导血管平滑肌细胞钙化的作用[J].中山大学学报(医学科学版),2009,30(3):255-258. 被引量:2
  • 2Parhami F,Morrow A D,Baluean J,et al.Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation.A possible explanation for the paradox of arterial calcification in osteoporotic patients[J].Arterioscler Thromb Vasc Biol,1997,17(4):680-687.
  • 3Bear M,Butcher M,Shaughnessy SG.Oxidized lowdensity lipoprotein acts synergistically with betaglycerophosphate to induce osteoblast differentiation in primary cultures of vascular smooth muscle cells[J].J Cell Biochem,2008,105(1):185-193.
  • 4Proodfoot D,Skepper JN,Hegyi L,et al.Apoptosis regulates human vascular calcification in vitro:evidence for initiation of vascular calcification by apoptotic bodies[J].Circ Res,2000,87(11):1055-1062.
  • 5Shroff RC,MeNair R,Figg N,et al.Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis[J].Circulation,2008,118(17):1748-1757.
  • 6Iyemere VP,Proudfoot D,Weissberg PL,et al.Vascular smooth muscle cell phenotypic plasticity and the regulation of vascular calcification[J].J Intern Med.2006,260(3):192-210.
  • 7Lu L,Wu W,Yah J,et al.Adriamycin-induced autophagic cardiomyocyte death plays a pathogenic role in a rat model of heart failure[J].Int J Cardiol,2009,134(1):82-90.
  • 8Jia G,Cheng G,Agrawal DK.Autophagy of vascular smooth muscle cells in atherosclerotic lesions[J].Autophagy,2007,3(1):63-64.
  • 9Martinet W,De Meyer GR.Autophagy in atherosclerosis:a cell survival and death phenomenon with therapeutic potential.Cire Res,2009,104(3):304-317.
  • 10Mistiaen WP,Somers P,Knaapen MW,et aL Autophagy as mechanism for cell death in degenerative aortic valve disease[J].Autophagy,2006,2(3):221-223.

二级参考文献11

  • 1Steitz SA,Speer MY,Curinga G,et al.Smooth muscle cell phenotypic transition associated with calcification:upregulation of Cbfa1 and downregulation of smooth muscle lineage markers[J].Circ Res,2001,89(12):1147-1154.
  • 2Cheng SL,Yang JW,Rifas L,et al.Differentiation of human bone marrow osteogenic stromal cells in vitro:induction of the osteoblast phenotype by dexamethasone[J].Endocrinology,1994,134(1):277-286.
  • 3Fischer JW,Steitz SA,Johnson PY,et al.Decorin promotes aortic smooth muscle cell calcification and colocalizes to calcified regions in human atherosclerotic lesions[J].Arterioscler Thromb Vesc Biol,2004,24(12):2391-2396.
  • 4Moreno M,Mu(n)oz R,Aroca F,et al.Biglycan is a new extracellular component of the Chordin-BMP4 signaling pathway[J].EMBO J,2005,24(7):1397-1405.
  • 5Chen XD,Fisher LW,Robey PG,et al.The small leucine-rich proteoglycan biglycan modulates BMP-4-induced osteoblast differentiation[J].FASEB J,2004,18(9):948-958.
  • 6Kurodn M,Sasamura H,Shimizu-Hirota R,et al.Gluocrticoid regulation of proteoglycan synthesis in mesangial cells[J].Kidney Int,2002,62(3):780-789.
  • 7Trion A,Schutte-Bart C,Bax WH,et al.Modulation of calcification of vascular smooth muscle cells in culture by calcium antagonists,statins,and their combination[J].Mol Cell Biochem,2008,308 (1-2):25-33.
  • 8Xu T,Bianco P,Fisher LW,et al.Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice[J].Nat Genet,1998,20 (1):78-82.
  • 9Bereczki E,S(a)ntha M.The role of biglycan in the heart[J].Connect Tissue Res,2008,49(3):129-132.
  • 10Bochaton-Piallat ML,Ropraz P,Gabbiani F,et al.Phenotypic heterogeneity of rat arterial smooth muscle cell clones:implications for the development of experimental intimal thickening[J].Arterioscler Thromb Vasc Biol,1996,16(6):815-820.

共引文献1

同被引文献79

  • 1Santos RD, Nasir K, Carvalho JA, Raggi P, Blumenthal RS. Coronary calcification and coronary heart disease death rates in different countries, not only the influence of classical risk factors. Atherosclerosis. 2009,202(1):32-33 2.
  • 2Lloyd-Jones D, Adams R, Carnethon M, De Simone G, et al. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009,119(3):480-486 3.
  • 3Shroff RC, McNair R, Figg N, Skepper JN, Schurgers L, Gupta A, Hioms M, Donald AE, Deanfield J, Rees L, Shanahan CM. Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation. 2008,118(17):1748-1757 4.
  • 4Zeini m, L pez fontal R, Traves P G. Differential sensitivity to apoptosis among the cells that contribute to the atherosclerotic disease. Biochem Biophys Res Commun, 2007,363(2):444-450 5.
  • 5Henley C, Davis J, Miller G, et al. The AMG 641 abrogates parathyroid hyperplasia, bone and vascular calcification abnormalitieS in uremic rats. EurJPharmacoL2009, 616( l- 3) : 306- 313 6.
  • 6Chen NX, O'Neill KD, Chen X, et al. Annexin-mediated matrix vesicle calcification in vascular smooth muscle cells. Journal of Bone andMineral Research. 2008, 23(11): 1798-1805 7.
  • 7Reynolds JL, Joannides A J, Skepper JN, et al. Human Vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: A potential mechanism for accelerated Vascular calcification in ESRD. J Am SocNephrol. 2004, 15(11): 2857-2867 8.
  • 8Kockx MM, De Meyer GR, Muhring J. Apoptosis and related proteins in different stages of human atherosclerotic plaques. Circulation. 1998, 97(23): 2307-2315 9.
  • 9Anderson HC. Molecular biology of matrix vesicles. Clin Orthop 1995, (314): 266 -280 10.
  • 10Kim KM. Apoptosis and calcification. Scanning Microscopy 1995, 9(4): 1137-1178 11.

引证文献11

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部